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To determine whether obesity, inﬂammation, or conventional risk factors are related to depressive symptoms (DeprSy) in the
general population. Responses to 3 questions served to assess sense of depression. Body mass index (BMI), C-reactive protein
(CRP), and other epidemiologic data of participants were available. In 1940, individuals who consulted a psychiatrist in the
preceding year, or felt depressed (together DeprSy), 248 were female. Logistic regressions for adjusted associations of BMI with
DeprSy were not signiﬁcant as was serum CRP level. Diabetes and, in men, fasting glucose concentrations were associated with
DeprSy. Systolic blood pressure (SBP) was robustly inversely associated with DeprSy in diverse models at ORs of 0.74 (95%CI 0.63;
0.89) independent of confounders, including antihypertensive and lipid-lowering medication. The use of antidepressants could
not explain the reduced BP. Women are predisposed to depression with which, not BMI and CRP, but SBP is inversely associated.
Anti-inﬂammatory substances produced in depressed persons might explain the slightly lower BP.
1.Introduction
Evidence is available for the association of both obesity and
depressive disorder with increased risk of coronary heart dis-
ease (CHD) incidence [1], mortality [2], hypertension [3]
and diabetes [4]. Obesity is a greater risk factor than depres-
sion for metabolic complications and cardiovascular disease
[5]. Depression and severity of depressive symptoms
(DeprSy) are both important and independent risk factors
for the development and progression of cardiovascular dis-
ease in the general population, as well as in patients with
cardiovascular disease [6]. However, among 1794 partici-
pants of the population-based Canadian Nova Scotia Health
Survey, increased inﬂammation explained only a very small
proportion of the association between depression and inci-
dent CHD [7]. There may be a link between obesity and de-
pression, but whether depression leads to obesity or obesity
causes depression is unclear. A study that conﬁrmed that
obesity plays a pivotal role in inﬂammatory processes re-
levant to cardiovascular risk in women with polycystic ovary
syndrome did not support a correlation of depression with
chronic low-grade inﬂammation in this syndrome [8].
Underlying mechanisms such as chronic inﬂammation
have been extensively investigated as candidate pathways that
subsequently link obesity and depression in an attempt to
explain how each confers vulnerability to the other and sub-
sequentlyelevateastheriskforphysicalillness[9].Anumber
of cytokines were elevated among depressed individuals, in-
cluding interleukin-6 (IL-6) and C-reactive protein (CRP)
whichhasbeenshowntopredictcardiacmorbidityandmor-
tality [10]. A recent meta-analysis [11], focused on 8 cyto-
kines examined in various studies on depression, found that
only TNF-α and IL-6 were signiﬁcantly elevated in depressed
compared with control subjects; authors concluded that evi-
dence was strengthened that depression is accompanied by
the activation of the inﬂammatory response system. Little is2 Cardiology Research and Practice
known about the behavioral and biological mechanisms
through which depression becomes associated with inﬂam-
mation.Somestudiessuggestedthatdepressivemoodmaybe
partly responsible for inﬂammatory processes, and inﬂam-
matory processes may induce depressive symptoms in men
[12].
Weaimedtoinvestigatewhetherobesity,systemicinﬂam-
mation,oraconventionalcardiovascularriskfactorisrelated
to DeprSy in a representative sample of a middle-aged and
elderly general population by using body mass index (BMI),
serum CRP as markers, and other risk factors including
blood pressure. Such information could serve at least a two-
fold purpose, namely, (a) regarding utility for screening de-
pressedindividualsinthepopulationatlargeand(b)asaref-
erence information of possible use in future trials with
weight-reducingdrugsindiﬀerentiatingpotentialsideeﬀects
of depression.
2. Methods
2.1. Sample Population. This study sample was composed of
participants of the 2008/09 follow-up survey of the Turkish
Adult Risk Factor (TARF) Study. The TARF is a longitudinal
study on the prevalence of cardiac disease and risk factors
in a representative sample of adults in Turkey carried out
periodically almost biennially since 1990 in 59 communities
throughout all geographical regions of the country [13].
Details of the overall sampling were described previously
[14].Thestudywasapprovedby theEthicsCommittee ofthe
Istanbul University Medical Faculty. Written informed con-
sent was obtained from all participants. Partial logistic sup-
port was provided by the Turkish Ministry of Health. Data
were obtained by history of the past years via a structured
questionnaire, physical examination of the cardiovascular
system, sampling of blood, and recording of a resting 12-lead
electrocardiogram. The study group which consisted of 3/5s
of the whole cohort was similar to the latter with respect to
age, sex distribution, proportions of MetS, and type-2 dia-
betes.
2.2. Assessment of Depressive Mood by Interview. Following
3 questions were directed to participants during face-to-face
interview by a physician at his 4th year of specialization.
Questions were to be replied by Yes/No; the second query in-
cluded a subsidiary question. Clariﬁcation was given by
interviewer, when necessary.
(1) Did you consult in the past year a physician due to a
change in your mood or spirits?
(2) Do you feel depressed? If so, do you use antidepres-
sant drugs?
(3) Have there been periods that life is not worth living
or that you thought of seriously harming yourself?
2.3. Measurement of Risk Factors. Blood pressure was mea-
sured with an aneroid sphygmomanometer (Erka, Bad T¨ olz,
Germany) in the sitting position on the right arm, and the
mean of two recordings 5min apart was recorded. Height
was measured without shoes using a measuring stick and
weight in light indoor clothes using scales. BMI was com-
puted as weight divided by height squared (kg/m2).
Blood samples were collected, spun at 1000g for 10 min-
utes, and shipped on cooled gel packs at 2–5◦C to Istanbul to
be stored in deep freeze at −75◦C, until analyzed at a central
laboratory. Serum concentrations of hsCRP were measured
by nephelometry (BN Prospec, Behring Diagnostics, West-
wood, MA, USA). Serum concentrations of total cholesterol,
fasting triglycerides, glucose, HDL cholesterol (HDL-C plus
2nd generation, directly without precipitation), and LDL
cholesterol (directly) were determined by using enzymatic
kits from Roche Diagnostics (Mannheim, Germany) with a
Hitachi 902 autoanalyzer. Serum fasting concentrations of
insulin were carried out by the electrochemiluminescence
immunoassayECLIAonRocheElecsys2010usingRochekits
(Roche Diagnostics, Mannheim, Germany).
2.4.Deﬁnitions. Inregardtocigarettesmoking,nonsmokers,
former smokers, and current smokers formed the categories.
Anyone who drank alcoholic drinks once a month or more
frequently was considered as alcohol consumer. Type 2
diabeteswasdiagnosedwiththecriteriaoftheAmericanDia-
betes Association [15], namely, by self-report or when plas-
ma fasting glucose was ≥7mmol/L or when 2-h postprandial
glucose was >11mmol/L.
2.5. Data Analysis. Descriptive parameters were shown as
mean ± standard deviation, estimated mean ± standard
error, or in percentages. Due to the skewed distribution, val-
ues derived from log-transformed (geometric) means were
used for CRP and insulin. t-tests and Pearson’s chi-square
tests were used to analyze the diﬀerences between means and
proportions of groups. Likelihood estimates and 95% con-
ﬁdence intervals (CIs) were obtained by the use of logistic
regressionanalysesinmodelsthatadjustedforpotentialcon-
founders in which the odds ratio (OR) was expressed in
termsof1-SDincrementoftheindependentvariable.Avalue
of P<0.05 on the two-tail test was considered statistically
signiﬁcant. Statistical analyses were performed using SPSS-
10 for Windows.
3. Results
1940 men and women who were interviewed in the months
of September of 2008 and of 2009 formed the sample popu-
lation;966 (49.8%)werefemale,and974(50.2%) male.1692
people (87.2%) negated all questions; these are referred to
as “healthy” (Figure 1). The remaining 248 individuals who
responded with 1 or more positive answers are referred to as
having a depressive symptoms (DeprSy). 189 subjects (9.8%)
consulted a physician (referred to as “consulters”), 52 of
whomdidnotfeeldepressedand137feltdepressed,(7%)[87
consulters used antidepressants, 25 felt suicidal]. Fifty-nine
subjects (3%) did not consult a physician, yet 35 of these felt
depressed, [13 used antidepressants and 4 felt suicidal] and
24 subjects felt suicidal.Cardiology Research and Practice 3
Sample population
n = 1940
No consult
n = 1751 Consulted
n = 189
Normal
n = 1692
Did not feel depressed
n = 52
Felt depressed
n = 137
Mental disorder
n = 59
Felt depressed
n = 35
Felt suicidal n = 24
Figure 1: Diagrammatic representation of the responses of participants to the interview.
Females were signiﬁcantly more often DeprSy than males
(19.8% versus 6/2%, P<0.001) (Table 1). Women with
DeprSy were by 2.9 years younger and had by 6.4/2.6mmHg
lower BP values than healthy women (P = 0.001 in each).
Among men, no signiﬁcant diﬀerences were found between
these groups. Presence of CHD (P = 0.69 in men, 0.95 in
women) or diabetes (P = 0.12 in men, 0.47 in women) was
notrelatedtoDeprSy.Prevalenceofcurrentsmokingwasnot
diﬀerent among DeprSy in either sex, nor was that of alcohol
usage.
3.1. Association of Individuals with Depressive Symptoms and
Other Variables. Table 2 shows results of a logistic regression
analysis for the association of DeprSy. The ﬁrst model com-
prised sex, age, BMI, and SBP and disclosed that SBP and sex
were signiﬁcant variables (the odds of DeprSy in women was
4-fold the odds for men). In Model 2, smoking status and
fastingglucose,usageofantihypertensive,andlipid-lowering
drugs were added to the previous variables. SBP retained
its independent signiﬁcant OR. One SD increment of SBP
was inversely associated with DeprSy, at an OR 0.74 in the
total sample. This did not reach signiﬁcance in men but
showed a similar OR as in women. Age, smoking status, and
BMI persisted not to be associated. Fasting glucose was sig-
niﬁcantly associated only in men, OR being 1.27 (95%CI
1.00; 1.55), and at borderline signiﬁcance in combined gen-
ders. When diabetes replaced fasting glucose in the latter
model (comprising 1771 subjects with 215 DeprSy), OR was
borderline signiﬁcant 1.47 (95%CI 0.99; 2.18) in combined
genders but did not reach signiﬁcance in men alone [1.65
(0.83; 3.28)]. Overweight women, compared with normal-
weight women, tended weakly to DeprSy (OR 1.47, P<
0.14), after adjustment for age and smoking status.
3.2. Stratiﬁed Analysis by Use of Antidepressants. When the
association between DeprSy and SBP was scrutinized by stra-
tifying for individuals using antidepressive drugs, partici-
pants reporting the use of antidepressants (n = 100) had
an age-adjusted mean SBP only 1.3mmHg lower in men
(P = 0.71), 0.9mmHg lower in women (P = 0.73), than
the remainder of the study sample.
When only consulters were analyzed by multiple logistic
regression again in the 2 similar models (Table 3), excluding
those who were in depressed mood but somehow did not
consult a physician, fasting glucose was not associated
though sex and (inversely) SBP proved to be signiﬁcantly
associated at virtually identical ORs of 0.75.
In a further model, we examined in 1745 subjects the
association of CRP with DeprSy, along with BMI, SBP, and
other variables (Table 4, model 2). CRP, BMI, and smoking
status persisted not to be associated whereas female sex (4-
fold), and, inversely, SBP was highly signiﬁcantly associated
[OR 0.72 (95%CI 0.60; 0.85]. Serum CRP disclosed for a 3-
fold increment an OR of 0.98 (95%CI 0.88; 1.08).
4. Discussion
Salient ﬁndings in this population-based study seeking the
relationship between depression and obesity/inﬂammatory
markers and conventional cardiovascular risk factors was
that, while BMI and serum CRP level were not associated,
female sex and fasting glucose were signiﬁcantly associated
with DeprSy. Noteworthy was that SBP was inversely and
robustly associated with DeprSy in the total study sample.
Our ﬁnding relative to a current depressive disorder in
this middle-aged population to prevail in 6.2% in men, and
19.8% of women is coarsely in line with the reported pre-
valence of a major lifetime depression among 6914 young
US adults from the NHANES-III survey as 5.7% in men and
11.7%inwomen,corresponding toatwo-foldriskinwomen
as in men [16]. Among 1600 Chinese people aged 60 years
or over, the age-standardized prevalence of depression was
found as 6%, and female sex was independently associated
[17]. The preponderance of women was stronger among
Turks inasmuch as the multivariably adjusted OR of DeprSy4 Cardiology Research and Practice
Table 1: Baseline characteristics of the sample population (n = 1940), by gender and mental disorder.
Women (n = 966) Men (n = 974)
Healthy (n = 778) Depres. disorder∗ (n = 188) Healthy (n = 914) Depres. disorder∗ (n = 60)
Mean SD Mean SD Mean SD Mean SD
Age, years 57.5 11 54.6 9.8 56.4 11 56.3 11.7
Systolic blood pressure, mmHg 129.0 21 122.6 21.3 121.9 19 118.6 16.4
Diastolic blood pressure, mmHg 77.0 10.3 74.4 10 74.7 10 74.1 9.6
Current smoker, n. % 92 13 26 15.4 306 38 18 36
Alcohol user, n. % 2 0.3 2 1.2 102 12.5 7 13.7
Body mass index, kg/m2 31.2 6 31.3 5.6 28.2 4.3 27.8 4.1
Fasting glucose, mg/dL 102.3 40.2 104.8 48 102.7 39.7 116.1 60.6
Total cholesterol, mg/dL 199.7 44.4 206 42.1 198 41.8 192.6 37.7
HDL cholesterol, mg/dL 48.1 12.4 49.6 13.5 40.6 11 40.9 8
Fast. triglycerides, mg/dL 177.2 117 190.7 168 177.2 117 190.7 168
Fasting insulin, mIU/L 8.64 2.02 8.74 2.00 8.28 2.05 9.17 2.04
C-reactive protein, mg/L 2.50 2.88 2.35 2.92 2.04 2.73 1.73 2.9
Presence of CHD, n. % 80 10.3 19 10.2 122 13.4 9 15.3
Presence of diabetes, n. % 119 15.5 33 17.6 135 15.3 13 23.2
∗includes those who consulted a physician or felt depressed without having consulted a physician.
P<0.002 in boldface, 0.067 in italics; all other values between healthy and mental disorder are >0.1.
Table 2: Logistic regression analysis for the association of certain parameters with depressive disorder, by gender.
Total Men Women
OR 95% CI OR 95% CI OR 95% CI
Model 1 241/1919† 57/963† 184/956†
Female gender 3.97 2.87; 5.49
Age, 11 years 0.91 0.77; 1.06 1.07 0.82; 1.41 0.85 0.70; 1.02
Body mass index, 5kg/m2 1.08 0.94; 1.23 0.97 0.69; 1.35 1.10 0.96; 1.28
Systolic b. pressure, 20mmHg 0.74 0.63; 0.87 0.80 0.58; 1.10 0.72 0.60; 0.89
Model 2 189/1594† 49/822† 140/772†
Female gender 3.48 2.20; 5.52
Age, 11 years 0.90 0.76; 1.07 1.04 0.77; 1.44 0.84 0.68; 1.03
Body mass index, 5kg/m2 1.01 0.87; 1.18 0.99 0.85; 1.43 1.03 0.87; 1.22
Systolic b. pressure, 20mmHg 0.74 0.62; 0.89 0.75 0.52; 1.06 0.74 0.60; 0.92
Fasting glucose, 40mg/dL 1.13 1.00; 1.32 1.27 1.00; 1.55 1.08 0.89; 1.27
Current versus never smoking 0.83 0.45; 1.53 0.92 0.42; 2.00 0.99 0.30; 3.28
Antihypert. drug use, yes/no 1.19 0.83; 1.73 1.20 0.73; 1.81 1.17 0.76; 1.79
Lipid-lower. drug use, yes/no 1.08 0.63; 1.88 1.07 0.54; 2.08 1.03 0.54; 1.97
†number of depressive disorder/total number.
201/61 antihypertensive/lipid-lowering drug usage in men, 322/75 usage in women, respectively.
Signiﬁcant values are highlighted in boldface.
for women was consistently 3.9-fold than the odds for men.
AgewasnotrelatedtoDeprSyinmenbutyoungeragetended
to be a predisposing covariate among women. Younger age
andfemalesexcorrelatedsigniﬁcantlywithdepressionalsoin
persons with severe obesity [18]. DeprSy was independently
associated with fasting glucose in men and tended to be so
with the presence of diabetes in both genders. Though this
association was weaker, it is in concordance with a previous
meta-analysisinwhichthepresenceofdiabeteswasshownto
double the odds of comorbid depression [19].
4.1. Lack of Association of BMI and CRP with Depression.
Mean BMI in the NHANES-III survey was not signiﬁcantly
diﬀerent in persons with than without a major depression
(25.8 versus 25.4kg/m2, P = 0.42) (16) though adjusted
analyses were not made.
Among young US adults from the NHANES-III survey,
anelevatedCRP(≥2.14mg/L)wasobservedin13.7%ofmen
and 27.3% in women. Elevated levels were not associated in
multivariably adjusted with current or lifetime depression
in females with which our ﬁndings are in agreement. NoCardiology Research and Practice 5
Table 3: Logistic regression analysis for the association of certain parameters with individuals consulting a physician, by gender.
Total Men Women
OR 95% CI OR 95% CI OR 95% CI
Model 1 184/1919† 42/963† 142/956†
Female gender 3.98 2.76; 5.76
Age, 11 years 0.95 0.79; 1.12 1.18 0.88; 1.61 0.86 0.70; 1.06
Body mass index, 5kg/m2 1.07 0.93; 1.24 0.92 0.62; 1.36 1.10 0.94; 1.29
Systolic b. pressure, 20mmHg 0.75 0.63; 0.92 0.80 0.56; 1.17 0.75 0.62; 0.94
Model 2 147/1594† 36/822† 111/772†
Female gender 3.39 2.02; 5.68
Age, 11 years 0.91 0.75; 1.10 1.09 0.76; 1.56 0.84 0.66; 1.06
Body mass index, 5kg/m2 1.05 0.89; 1.23 0.94 0.61; 1.46 1.07 0.89; 1.28
Systolic b. pressure, 20mmHg 0.75 0.62; 0.94 0.75 0.51; 1.13 0.79 0.62; 1.00
Fasting glucose, 40mg/dL 0.96 0.82; 1.17 1.08 0.79; 1.43 0.92 0.76; 1.17
Current versus never smoking 0.80 0.40; 1.60 0.97 0.40; 2.35 0.95 0.25; 3.59
Antihypert. drug use, yes/no 1.23 0.82; 1.85 1.99 0.91; 4.34 1.05 0.65; 1.68
Lipid-lower. drug use, yes/no 0.92 0.48; 1.75 0.90 0.26; 3.15 0.90 0.43; 1.90
†number of consulters/total number.
Antihypertensive/lipid-lowering drug usage in 523/136 men and women, respectively.
Signiﬁcant values are highlighted in boldface.
diﬀerence in BMI, nor in TNF-α or IL-6 concentrations, was
observed with depression in 63 obese Polish women [20].
Analysisofextensiveinﬂammatorybiomarkersandadiposity
measures in 57 patients with polycystic ovary syndrome and
28 healthy women did not support a correlation of depre-
ssion with chronic low-grade inﬂammation in women with
this syndrome [8]. The case-control study by Miller on 100
young adults [21] also did not support a model in which in-
ﬂammatory molecules arising from expanded adipose tissue
promoted depressive symptoms but rather that depressive
symptoms promoted weight accumulation with subsequent
low-grade inﬂammation.
Level of IL-6 was not independently associated with ele-
vated depressive symptoms also in a study on 416 Finns, but
levelsoftheanti-inﬂammatoryIL-1receptorantagonistwere
exhibited an OR over 2-fold compared to those not belong-
ingtothegroupwithelevateddepressivesymptoms[22].Au-
thors concluded that the pronounced secretion of the anti-
inﬂammatory marker IL-1 receptor antagonist may reﬂect
the presence of compensatory mechanisms during a depres-
sion-related inﬂammatory state.
4.2. Inverse Relation of Blood Pressure to Depression. The sur-
prising and main ﬁnding in the current study was that BP
was lower in depressed subjects (in the order of 5/2mmHg)
which could not be accounted for by age, smoking status,
BMI, glucose, or CRP. The odds for DeprSy in multivariable
analyses were consistently lower by one-quarter for a 1-SD
increment in SBP in each gender (though failing to reach
signiﬁcance in men because of limited statistical power).
Although reasons for it may be unclear, this association was
robust, exhibiting a narrow conﬁdence interval and preserv-
ing the OR in variously adjusted models in each gender. In
subgroup analyses, we could exclude the use of antidepres-
sants as possibly accounting for this ﬁnding.
This ﬁnding does not seem to be speciﬁc for the current
study. Though in elderly Chinese, not detected hypertension
but undetected severe hypertension (≥160/95mmHg) was
reported to be associated with depression (OR 1.78; [95%CI
1.05; 3.01]) (17) that may have been related to a high BMI or
to diabetes for which adjustment was not made. In young US
adults from the NHANES-III survey, mean SBP was lower by
1.5mmHg in persons with than without a major depression
(P = 0.09) [16]. A relationship between depression and low
SBP was shown in Koreans in whom the lowest SBP decile of
the study sample, regardless of antihypertensive medication,
had signiﬁcantly elevated odds for depression compared to
the median quintile of the sample [23]. Moreover, previous
studies reported low systolic BP in segments of population in
whom self-perceived physical and mental well-being was low
[24, 25]. Finally, through the examination of the National
Nursing Home Survey database, Rosengren et al. [26]f o u n d
that the use of any antihypertensive agent (among over 7200
nursing home residents) was associated with a decreased
likelihood (0.76 [95%CI 0.63; 0.90]) of a diagnosis of de-
pression.
It has been proposed that anti-inﬂammatory substances
(including anti-inﬂammatory cytokines IL-4 and IL-10) or
IL-1 receptor antagonist [22] may compensate for pronoun-
ced proinﬂammatory changes in depressed individuals. The
latter is a speciﬁc inhibitor of the depression-related cyto-
kines IL-1α and IL-1β secreted by activated monocyte/mac-
rophage lineage cells [27]. The development of prehyperten-
sion among Turks, especially women, has been shown by
us to be signiﬁcantly predicted by pro-inﬂammatory status
marked by CRP [28] and/or apoA-I levels (unpublish-
ed observations). It may be hypothesized that anti-inﬂam-
matory substances, produced in depressed persons, might
counteract pro-inﬂammatory state and result in slightly low-
er BP than in nondepressed individuals in whom this6 Cardiology Research and Practice
response may be less active. In fact, a concept referring to an
adaptive response to the pronounced secretion of inﬂamma-
tory substances has been designated as compensatory anti-
inﬂammatory response syndrome [29].
Limitations. The assessment of depression herein is limited
by using the indicators of such a disorder rather than a
diagnosed depression. The reliability and validity of our
questionnaire has not been formally tested in community
samples, but it is congruent with the essence of the Beck De-
pression Inventory commonly utilized in clinical [18] or epi-
demiologic studies. Responses to treatment and treatment
seeking might not perfectly correspond to DeprSy or de-
pression. The cross-sectional design precludes the drawing
of conclusions on causality of present ﬁndings. Though an
association between CRP and depressive disorder was lack-
ing, a possible association of inﬂammation cannot be exclu-
ded in this sample, considering that association with depres-
sion of inﬂammatory mediators other than CRP (chemo-
kines and cytokines such as MCP-1, MIP-1α,T N F α,I L - 1 β,
IL-6, interferon activity, etc. [30]) originating from tissues
other than adipose tissue such as macrophages and T cells
[11] has been demonstrated. Main ﬁndings cannot be attri-
buted to a type-2 error, given both the robust result under
diverse regression models and their consistency with avail-
able ﬁndings elsewhere, albeit scarce. Additional sensitivity
analysis for depression treatment failed to show a signiﬁcant
association. The current population-based study on a large
cohort in which measurements for anthropometric and lipid
and nonlipid variable were available for performing multi-
variable adjustments form the strength of this study.
We conclude that, in a middle-aged and elderly general
population, a depressive symptoms prevail at 4-fold odds in
women. BMI and CRP were not associated, but fasting glu-
cose was associated in men with likelihood for DeprSy. Sur-
prisingly, systolic BP was robustly associated inversely with
depression which may be attributable to a compensatory
anti-inﬂammatoryresponseindepressedpersons,reversinga
tendency to prehypertension mediated by pro-inﬂammatory
stateinthispopulation.Thisobservationneedsconﬁrmation
in other populations.
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